CURAIZON
health care designed to improve medication adherence
We solve real problems by really helping patients to take their medicine correctly. Medical researchers are challenged to find better new medicines and treatments for chronic diseases. But what if the answer to improving health outcomes will be easier for many patients than developing new medicines? What if it is very easy to ensure that more patients maintain their treatment regimen?
Medical disobedience is a big challenge throughout the world. According to the World Health Organization, half of patients with chronic conditions such as HIV, cancer and high blood pressure are not on treatment plans - and the level is even lower in developing countries. While low compliance means that individual patients have greater difficulty in treating the disease, it also causes large costs for health and insurance companies.
To date, many doctors have relied on low-tech solutions to improve medical compliance - such as providing patients with labeled pill boxes or sending digital reminders via email or SMS. Although this tactic helps improve compliance, there is a smarter solution: Internet of Things.
CuraToken ™ values are based on true solutions to real problems.
Play videos and learn more about Curaizon ™
feature
CuraServe is a health care system designed to improve medication adherence and to benefit patients and health care providers. Curaizon uses a set of outreach tools and messages that are supported by predictive modeling and behavioral analysis to improve drug adherence. Because the CuraServe solution helps patients, patient data is also produced. The data is then anonymized and available through CuraData. Only then can pharmaceutical companies, scientists, and researchers be able to access this data by purchasing Cura Tokens.
The CuraServe ™ solution generates information that drives the value of the CuraData ™ platform. Curazon data provides real-time insight into patient behavior and compliance. Collaborating with research institutions, national health services, and biotechnology companies, Curazon aims to create valuable data sources in health care.
What is the company doing?
Our goal is to improve the compliance and drug benefits that will change the game for patients and healthcare providers by becoming a global leader in compliance and data solutions.
What is unique about the company?
Our solutions work with patients, their families and health care providers to ensure that patients take their medication as specified in a set of outreach tools, supported by predictive modeling tools and behavioral analysis to improve drug adherence.
What problems did the company solve?
Our CuraServe technology helps ensure that patients take their medicine as determined by their doctor. In this way, we help patients live longer and healthier lives. We also reduce health care costs if the patient does not take medication properly.
How do you create value to support your CuraTokens?
Our CuraServe ™ technology generates a large amount of unique and real-time data that shows how people use their most valuable drugs for different groups, including pharmaceutical companies, medical researchers, and biotechnology companies. With CuraTokens ™, the token owner can access data to make queries. When our solutions are introduced to more patients in several countries. The more data we produce, the more valuable CuraTokens ™.
Who is your target customer?
Curaizon ™ sells its compliance solutions (CuraServe ™) to national health services worldwide. Our end users are health care patients who take any form of medicine. We also work with academics, pharmacy, biotechnology and other data users through our CuraData ™ solution.
What is your geographic market target?
Curaizon targets countries with national health services. Currently it covers 1.4 billion people and this number continues to grow.
What is the market potential?
Costs of non-compliance around the world amount to more than 600 billion euros each year, causing hundreds of thousands of lives to be lost prematurely. Compliance with chronic and long-term diseases is less than 50%.
Curaizon ™ Ecosystem
January 2016
Development of CuraServe ™ Start
June 2017
The CuraServe ™ test takes place
February 2018
Full version of Alpha CuraData ™
1. June 2018
Start the token presale
8. June 2018
Public Token Sales begin
November 2018
Full beta version of CuraData
March 2019
CuraServe ™ release
July 2019
Growth of the CuraData ™ platform
2020
Release of Curadata ™ 2.0
Our team combines passion, innovation and expertise with experience in the fields of health, finance, operations, marketing and technology
LEADERSHIP
BUSINESS
consultant
For more information link below:
Tidak ada komentar:
Posting Komentar